Celera s Chinese Subsidiary Pens SNP Deal with Macrogen of S. Korea | GenomeWeb

NEW YORK, Feb 22 - Celera’s Chinese subsidiary Shanghai GeneCore Biotechnologies and Macrogen of South Korea have penned an agreement to jointly develop a SNP database, The Korea Times said Wednesday.

Macrogen, which offers custom sequencing services and has developed DNA chips as well as a set of customized transgenic mice, is currently exploring SNP patterns in the Korean population as part of its effort to branch into personalized medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.